Cite
Discovery of pyrazolopyrrolidinones as potent, broad-spectrum inhibitors of Leishmania infection
MLA
John A. Kavouris, et al. Discovery of Pyrazolopyrrolidinones as Potent, Broad-Spectrum Inhibitors of Leishmania Infection. Jan. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ca89de57925ec53ca70b886fe99830eb&authtype=sso&custid=ns315887.
APA
John A. Kavouris, Laura-Isobel McCall, Miriam A. Giardini, Geraldine De Muylder, Diane Thomas, Adolfo Garcia-Pérez, Juan Cantizani, Ignacio Cotillo, Jose M. Fiandor, James H. McKerrow, Camila I. De Oliveira, Jair L. Siqueira-Neto, Silvia González, Lauren E. Brown, & Scott E. Schaus. (2023). Discovery of pyrazolopyrrolidinones as potent, broad-spectrum inhibitors of Leishmania infection.
Chicago
John A. Kavouris, Laura-Isobel McCall, Miriam A. Giardini, Geraldine De Muylder, Diane Thomas, Adolfo Garcia-Pérez, Juan Cantizani, et al. 2023. “Discovery of Pyrazolopyrrolidinones as Potent, Broad-Spectrum Inhibitors of Leishmania Infection,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ca89de57925ec53ca70b886fe99830eb&authtype=sso&custid=ns315887.